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In the last decade, researchers in the social sciences have increasingly adopted
neuroscientific techniques, with the consequent rise of research inspired by neuroscience
in disciplines such as economics, marketing, decision sciences, and leadership. In 2007,
we introduced the term organizational cognitive neuroscience (OCN), in an attempt to
clearly demarcate research carried out in these many areas, and provide an overarching
paradigm for research utilizing cognitive neuroscientific methods, theories, and concepts,
within the organizational and business research fields. Here we will revisit and further
refine the OCN paradigm, and define an approach where we feel the marriage of
organizational theory and neuroscience will return even greater dividends in the future
and that is within the field of clinical practice.
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INTRODUCTION
In this article the clinical concept of the “therapeutic gap” is
discussed in light of the “research-practice gap” central to ongoing
debate within business research. Inspired by Grimshaw et al.
(2012), we explore two key questions; what types of business
research could offer clinical insights, and how? What are the
pitfalls such research may encounter, with particular regard to
translational practices and public understanding? Such issues are
vital in light of the ever-increasing public interest in translational
neuroscience, and especially in the findings of such research as
applied to our own lives as employees and consumers (see e.g.,
O’Connor et al., 2012). In partial answer to the first question, we
suggest that certain types of organizational cognitive neuroscience
(OCN; Senior et al., 2011) could provide a beneficial context in
which to conduct research with direct therapeutic implications.
In doing so, we show that taking account of such issues should
also lead to better science, and provide examples of research
that could be of use in this regard. Throughout, we address
the second question by pointing out significant concerns with
certain existing approaches to such research. Finally, we conclude
with a call to arms for researchers to consider the therapeutic
implications of their work, further drawing neuroscientific and
business researchers closer, ultimately leading to research with
greater translational potential.
ORGANIZATIONAL COGNITIVE NEUROSCIENCE AND THE
THERAPEUTIC GAP
Many scientists feel that the primary focus of their endeavors
should be on ensuring the scientific rigor of their methods, and
the ensuing creation of knowledge. While these are laudable
goals, knowledge translation can sometimes be overlooked. Yet,
the communication of any findings to the wider community of
relevance, in order that it be put into practice, is a vital part of the
wider role of science (Plebani and Marincola, 2006). Further, in
contemporary scientific environments, where scientists often have
to compete with other funding priorities, superior knowledge
translation can be of key importance in securing ongoing research
streams.
Across the social sciences, a common frustration concerns
the distance between the research activities carried out within
laboratories, and their subsequent practical application in the
real world (Cousins and Simon, 1996). This has been referred
to within the clinical sciences as the therapeutic gap, and is
generally regarded as being the fundamental barrier to developing
a comprehensive model of health behavior (Bero et al., 1998;
Grimshaw et al., 2012). Importantly, the therapeutic gap is not
merely an artefact of the publication delay so commonly criticized
by scientists. Rather, it is the gap between scientific publication
of research findings and their subsequent application towards the
development of evidence-based practice.
There have been several recent attempts to close the therapeu-
tic gap in our understanding of a range of diseases from a variety
of avenues—and perhaps the most surprising of these avenues
is from marketing science (Javor et al., 2013). In light of such
recent contributions, the utility of the emerging field of OCN is
discussed here as a framework for understanding how research
findings from the laboratory can be translated to clinical benefits.
OCN is an umbrella term that encompasses a variety of subor-
dinate domains, therefore the aforementioned neuromarketing as
well as neuroeconomics will be discussed further.
Beginning with neuroeconomics, this field has probably
seen the most prolific advancement in its approach to the
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translation of knowledge across a range of different domains
(Clithero et al., 2008). It is a field where various outputs do indeed
have direct implications across a rich and diverse constituency
(Levallois et al., 2012). It is also clear that such diversity has
immense potential to straddle different scientific disciplines and
in doing so connect distinct research networks, resulting in gen-
uinely innovative research collaborations (Christopoulos et al.,
2009).
The generation of such diverse research collaborations has
seen the development of a “trade language that facilitates com-
munication between disparate cultures” (Levallois et al., 2012,
p. 8). This common language, spanning several research areas and
laboratories, is facilitating the closure of the gap between research
and practice and in turn ensuring the rapid translation of research
findings from the laboratory into real world practice (Kishida,
2012). In fact, even though most neuroeconomic research is con-
strained by the traditional limitations of the laboratory (Kuhnen
and Knutson, 2005) such research has made significant discoveries
with direct clinical relevance.
One very notable example is seen with the work by Hackman
and colleagues, who uncovered a significant link between parental
socio-economic status and the subsequent neurocognitive devel-
opment of their offspring (Hackman and Farah, 2009; Hackman
et al., 2010). Here there is very clear link between parental eco-
nomic position and the health of family members at a cortical
level of analysis—a link that would have obvious implications
for subsequent clinical ontology. In this regard, the study of
economic theory has a direct role in understanding the cognitive
development of children. Thus, ceteris paribus, the application of
economic theory to improve the lives of the parents could improve
the cognitive development of their children. Here, one could
argue that the therapeutic gap has been reduced to a significant
degree—or even closed completely.
Beyond this, one can also observe the continuous generation of
new hypotheses, further elucidating areas of clinical interest. Take
recent work in the field of neuropsychiatry and the application
of computational theory to model psychiatric phenomena for
example (Montague et al., 2011). This approach is based on the
fundamentals of modeling economic exchange, and promises to
be a fertile area in the future with much clinical potential to
enhance the testing and approval of new drugs. Similarly, Hasler
(2012) has further developed the clinical potential of neuroeco-
nomics, describing the possible benefits of clinical interventions
based on the application of game theory (Hasler, 2012). Abnormal
social behavior can be formalized using behavioral game theory.
As such Psychiatry will benefit from neuroeconomics’ unified
theory of human behavior (Glimcher and Rustichini, 2004).
Ultimately such approaches will ensure that neuroeconomics will
have great clinical utility, helping to further narrow the therapeu-
tic gap in the years to come (Bernheim, 2009).
A second approach born from the OCN paradigm that
promises to help close the therapeutic gap is the emerging field
of neuromarketing (Lee et al., 2007). The steady evolution of this
specific approach is of particular importance in understanding the
therapeutic gap, because at its core neuromarketing is essentially
the application of neuroscience to understand decision-making
within a market context. Such fundamental market behaviors are
manifest throughout our entire repertoire of social behaviors and
address core questions regarding the human condition (Fisher
et al., 2010; Ouazzani Touhami et al., 2011). Thus, it is quite easily
conceivable that neuromarketing research may help to alleviate
a range of social pathologies (Montague et al., 2002; Babiloni
et al., 2007; Dumas et al., 2010; Babiloni and Astolfi, 2012; Tikka
et al., 2012). That said, while, reports in this regard have been
published in some of the most prestigious journals in the world
(The Lancet Neurology, 2004; Ariely and Berns, 2010), we would
urge at this juncture that more effort is needed before the true
utility of neuromarketing can be seen in this regard.
In fact, some would argue that it is neuromarketing itself that
has driven the onset of various pathologies such as compulsive
shopping and childhood obesity (Fisher et al., 2010; Jain, 2010),
even going so far as to say that “neuromarketing research is
also allowing advertisers to appeal to the subconscious to which
children may be particularly vulnerable” (Jain, 2010, p. 425). Of
course, we agree completely that pediatric (commercial) neu-
romarketing endeavors are simply untenable (Murphy et al.,
2008), and it is with the study of adult populations that we
will see neuromarketing science significantly close the therapeutic
gap.
However, this will see neuromarketing researchers embracing a
Faustian pact of sorts with critics. In particular, with the identifi-
cation of a discrete region in the human brain that is activated
for consumer behavior, it may be noted that we are implicitly
accepting the well-established fallacy of a “buy button” in the
brain (See Blakeslee, 2004). This though is something of a gross
over simplification, even though it should be acknowledged that
the various social processes that mediate financial exchange for
goods are starting to be mapped out. Such processes would be
viable candidates for therapeutic intervention, as long as they are
considered within the constraints of their cognitive domain. Here
we are assuming that any given brain area activated for a particular
social task must be involved in one (or many) subordinate tasks
that may drive the overarching social behavior.
While the complex processes that we undergo during a pur-
chase decision are beginning to be broken down and mapped to
various brain areas, we are as yet unable to show the specificity
of any area to any individual behaviors. Yet, by delineating the
social processes that mediate purchase exchanges, and mapping
each of these processes to a different network, it is possible to
interrogate cortical systems to identify how and why they are
involved in our daily purchase decisions. Only once such networks
have been identified can we then start to examine their role
in pathological states such as compulsive gambling or shopping
addiction (Aboujaoude et al., 2003).
While the simplistic belief in a “buy button” in the brain
has been widely ridiculed (e.g., http://www.russpoldrack.org/
2011/10/nyt-editorial-fmri-complete-crap.html), it is unavoid-
able that the cognitive architecture that drives purchase behavior
must indeed exist in some form. A more ecologically-valid way
of conceptualizing this architecture is to consider the complex
interactions that occur at neural network level during the vari-
ous social processes that occur during market exchanges. From
a neuroscientific perspective this is standard practice (see e.g.,
Friston, 2000), and we have previously urged scholars within the
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organizational sciences to adopt such an approach (Lee et al.,
2012). It is only with such a forward inferential model that
insights into compulsive pathology can be made (van Holst et al.,
2012). Here there is indeed great potential to close the therapeutic
gap in relation to impulse control disorders that occur within the
market (Aboujaoude et al., 2003; Black, 2007).
In a translational context, it is not enough to simply conduct
scientifically-rigorous research. Rather, the interpretation and use
of such research by non-scientists (such as clinical practitioners
and the general public) must be taken into account. Within a
neuroscience context, the inherent technical, philosophical, and
conceptual complexity places an even greater responsibility on
scientists in this regard. As such, complimenting the contributions
of neuroeconomics and neuromarketing is the recent grassroots
initiative within the neuroscience research fraternity to educate
its readers (Illes et al., 2010). For example, one can now expect,
as a matter of course, passionate rhetoric in response to research
reports that have failed to encapsulate a full description of the
limitations of the application of technologies such as fMRI for
example (Vul et al., 2009).1
The drive to empower a greater public (and by extension prac-
titioner) understanding of the brain has evolved from neuroethics
(Roskies, 2002; Farah, 2012; Shadlen and Roskies, 2012). A partic-
ular catalyst of these efforts is the finding that brain scan images
may have a persuasive effect on the reader (See also McCabe and
Castel, 2008; Farah and Hook, 2013). The significance of such an
effect has led to scholars calling for limits on the use of brain
scan imagery in areas such as the judiciary and national security
(Senior, 2008; Rippon and Senior, 2010), and has also seen calls to
develop regulatory processes that protect the various participants
when interacting with such technology (Garnett et al., 2011;
Farah, 2012). This has important implications with regards to
the therapeutic gap in clinical practice. Specifically, the rise of
such educational initiatives for both neuroscientists (Sahakian
and Morein-Zamir, 2009; Kehagia et al., 2012) and the general
public alike, will inevitably serve to develop a framework of
normative neuroscience that clearly describes the extent to which
any findings can be extrapolated to the real world, including
clinical practice.
One example is the recent attempts to change the way
that neuroscientific research is portrayed in non-academic
reports. This work has revealed that neuroscientific research
is afforded “substantial and authoritative weight” (p.725) on
the development of governmental policy (Racine et al., 2010).
In addition to this, research has also explored the ways that
neuroscientific research is portrayed within the pages of main-
stream newspapers (Rose, 2007). Indeed, in a recent study
on neuroscientific reporting in the public sphere, O’Connor
et al. (2012) found that neuroscience research was reported
within a small number of thematic contexts—such as brain
optimization or futuristic phenomena—and that this group-
1The neuroscience community is prolific in this regard and has ensured
that various caveats enter the public domain in high profile main-
stream publications as well see e.g., http://www.nytimes.com/2007/11/
14/opinion/lweb14brain.html and http://www.russpoldrack.org/2011/10/nyt-
letter-to-editor-uncut-version.html
ing was in fact a significant factor in the effective facilita-
tion of the transfer of knowledge from the research laboratory
to the real world (O’Connor et al., 2012). The authors are
unequivocal in stating the importance of fully understanding
the limitations of neuroscientific research and how they effect
applications in the real-world; “neuroscience does not take part
in a vacuum, and it is important to maintain sensitivity to the
social implications, whether positive or negative, it may have
as it manifests in real-world contexts. It appears that the brain
has been instantiated as a benchmark in public dialogue, and
a reference to brain research is now a powerful rhetorical tool”
(p. 225).
Thus it would seem that the neuroscience community itself
is taking the vanguard with regard to closing the therapeutic
gap, and ensuring that any application of neuroscience research
is embedded within the realistic confines of its applicability.
However it remains to be seen whether future scientific results
from the neuroscience research community will result in a full
transfer of knowledge into the public domain, and whether
OCN as a context will facilitate this transfer. It is the for-
mation of a common trade language that spans across areas
such organizational behavior, marketing, and clinical therapy
that will return the greatest dividends in closing the therapeutic
gap.
CONCLUSIONS
Our interest here was to explore the idea that OCN research
could help drive improvements in clinical practice, helping to
close the therapeutic gap. Interactions and experiences in relation
to organizations, such as within the workplace, or the market,
provide much of what it means to be human in contemporary
society. It seems eminently logical that we begin to consider
whether investigation of our behavior within these contexts can
bear fruit in terms of improving the human condition. Certainly,
authors have not been shy in blaming contemporary human
problems on modern work, marketing, or media, and there-
fore it stands to reason that investigations of these phenomena
may be important directions in solving contemporary human
pathology.
As can be seen from the discussion above the translation
of knowledge from the organizational sciences to address the
therapeutic gap is currently underway. However, to facilitate
such translation further we would urge researchers to consider
five questions that have been designed to expedite knowledge
translation across various disciplines (Grimshaw et al., 2012).
What information should be transferred? To whom should it
be transferred? By whom? How? And with what effect? Taken
together these questions provide an organizing framework for a
highly effective knowledge transfer strategy and one that should
see research in the organizational fields making an impact within
the clinical domain (Lavis et al., 2003).
However, while we urge researchers in OCN-related fields
to consider the therapeutic implications of their work, we also
urge caution. In the move to embrace techniques such as fMRI,
it is easy to over-interpret findings and draw erroneous, and
potentially harmful, conclusions. This is particularly relevant
within organizational research contexts, where readers and users
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of research may have less experience and knowledge of how
to correctly interpret neuroscience findings. As always, we urge
researchers to form collaborative teams, including experts in all
fields of relevance. Such endeavors are vital when attempting
to draw clinical conclusions from OCN studies. Even so, we
hope researchers will take up this call to arms, and explore the
clinical potential of their work. In doing so, we envisage significant
advances beingmade towards the understanding and treatment of
many of the pathologies that plague our society.
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